Todd N. Brothers

Dr. Todd N. Brothers

University of Rhode Island, Kingston, Massachusetts, USA
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
OLOluwadolapo D. Lawal
Oluwadolapo D. Lawal
JGJustin Gold
Justin Gold
AMAmala Murthy
Amala Murthy
RRRupam Ruchi
Rupam Ruchi
EBEgle Bavry
Egle Bavry
XWXuerong Wen
Xuerong Wen
The misuse, overdose, and abuse of prescription opioids constitute sources of substantial morbidity and mortality in the US and globally.1-5 Approximately 130 individuals in the US die each day of opioid overdose, with one of the largest proportion of preventable deaths in the US being attributable to opioid-related deaths.3 In addition to the substantial mortality burden, prescription opioid misuse, abuse, dependence, and overdose were reported to cost the US health care system an estimated $78.5 billion in 2013.6 Increases in prescription opioid use and incidence of opioid-related deaths have also been reported globally, including in European countries and Canada.4,5,7-9

1 September 2007 in Critical Care Medicine
Verified
Journal Article
Closed access
MDMichael J. Dacey
Michael J. Dacey
EMEhsun Raza Mirza
Ehsun Raza Mirza
VWVirginia Wilcox
Virginia Wilcox
MDMaureen Doherty
Maureen Doherty
JMJames Mello
James Mello
RBRobert Baute
Robert Baute
To determine the effect of a rapid response system composed primarily of a rapid response team led by physician assistants on the rates of in-hospital cardiac arrests, total and unplanned intensive care unit admissions, and hospital mortality. Prospective, controlled, before and after trial. A 350-bed nonteaching community hospital. All adult patients admitted to the hospital from May 1, 2005, to October 1, 2006. We introduced a hospital-wide rapid response system that included a rapid response team (RRT) led by physician assistants with specialized critical care training. We measured the incidence of cardiac arrests that occurred outside of the intensive care unit, total intensive care unit admissions, unplanned intensive care unit admissions, intensive care unit length of stay, and the total hospital mortality rate occurring over the study period. There were 344 RRT calls during the study period. In the 5 months before the rapid response system began, there were an average of 7.6 cardiac arrests per 1,000 discharges per month. In the subsequent 13 months, that figure decreased to 3.0 cardiac arrests per 1,000 discharges per month. Overall hospital mortality the year before the rapid response system was 2.82% and decreased to 2.35% by the end of the RRT year. The percentage of intensive care unit admissions that were unplanned decreased from 45% to 29%. Linear regression analysis of key outcome variables showed strong associations with the implementation of the rapid response system, as did analysis of variables over time. Physician assistants successfully managed emergency airway situations without assistance in the majority of cases. The deployment of an RRT led by physician assistants with specialized skills was associated with significant decreases in rates of in-hospital cardiac arrest and unplanned intensive care unit admissions.

15 September 2020 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
PDF file
MAMohammad A. Al-Mamun
Mohammad A. Al-Mamun
TBTodd N. Brothers
Todd N. Brothers
ANAndrea Newsome
Andrea Newsome
Introduction: The Medication Regimen Complexity -Intensive Care Unit (MRC-ICU) is the first tool for measuring medication regimen complexity in critically ill patients. This study tested machine learning (ML) models to investigate the relationship between medication regimen complexity and patient outcomes. Methods: This study was a single-center, retrospective observational evaluation of 130 adults admitted to the medical ICU. The MRC-ICU score was utilized to improve the inpatient model’s prediction accuracy. Three models were proposed: model I, demographic data without medication data; model II, demographic data and medication regimen complexity variables; and model III: demographic data and the MRC-ICU score. A total of 6 ML classifiers was developed: k-nearest neighbor (KNN), naïve Bayes (NB), random forest, support vector machine, neural network, and logistic classifier (LC). They were developed and tested using electronic health record data to predict inpatient mortality. Results: The results demonstrated that adding medication regimen complexity variables (model II) and the MRC-ICU score (model III) improved inpatient mortality prediction.. The LC outperformed the other classifiers (KNN and NB), with an overall accuracy of 83%, sensitivity (Se) of 87%, specificity of 67%, positive predictive value of 93%, and negative predictive value of 46%. The APACHE III score and the MRC-ICU score at the 24-hour interval were the 2 most important variables. Conclusion and Relevance: Inclusion of the MRC-ICU score improved the prediction of patient outcomes on the previously established APACHE III score. This novel, proof-of-concept methodology shows promise for future application of the MRC-ICU scoring tool for patient outcome predictions.

13 November 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LALeonie Adjeroh
Leonie Adjeroh
TBTodd N. Brothers
Todd N. Brothers
KSKhaled Shawwa
Khaled Shawwa
MIMohammad Ikram
Mohammad Ikram
MAMohammad A. Al-Mamun
Mohammad A. Al-Mamun
Background and objective: The United States government spends over $85 billion annually on treating non-dialysis chronic kidney disease (CKD). Patients with CKD are prescribed a multitude of medications to manage numerous comorbidities associated with CKD. Thus, this study aims to investigate the association between polypharmacy and health-related quality of life (HRQoL) in non-dialysis CKD patients. Methods: This cross-sectional study utilized data from the Medical Expenditure Panel Survey (MEPS) from 2010 through 2019. We classified polypharmacy into three groups based on the number of medication classes: ≤ 4 (minor polypharmacy), 5 through 9 (major polypharmacy), and ≥ 10 (hyperpolypharmacy). To measure HRQoL, a Physical Component Summary (PCS) and a Mental Component Summary (MCS) were obtained from the 12-item Short-Form Health Survey version 2 and Veteran’s Rand 12 item. We applied multivariable ordinary least squares regression to assess the association between polypharmacy and HRQoL in non-dialysis CKD patients. Results: A total of 649 CKD patients (weighted n = 667,989) were included. Patients with minor polypharmacy, major polypharmacy, and hyperpolypharmacy were 22.27%, 48.24%, and 29.48%, respectively. Major polypharmacy and hyperpolypharmacy were significantly and negatively associated with lower PCS scores when compared with minor polypharmacy [Beta = -3.12 (95% CI: -3.62, -2.62), p-value<0.001; Beta = -4.13 (95CI: -4.74, -3.52), p-value<0.001]. Similarly, major polypharmacy and hyperpolypharmacy were significantly and negatively associated with lower MCS scores when compared to minor polypharmacy [Beta = -0.38 (95% CI: -0.55, -0.20), p-value<0.001; Beta = -1.70 (95% CI: -2.01, -1.40), p-value<0.001]. The top 5 classes of medications used by CKD patients were antihyperlipidemic (56.31%), beta-adrenergic blockers (49.71%), antidiabetics (42.14%), analgesics (42.17%), and diuretics (39.65%). Conclusion: Our study found that both major polypharmacy and hyperpolypharmacy were associated with lower HRQoL among non-dialysis CKD patients. This study highlights the need for further evaluation of the combination of medications taken by non-dialysis CKD patients to minimize unnecessary and inappropriate medication use.

3 July 2018 in Journal of Pain & Palliative Care Pharmacotherapy
Verified
Journal Article
Closed access
JOJordan O’lEary
Jordan O’lEary
JPJayne Pawasauskas
Jayne Pawasauskas
TBTodd N. Brothers
Todd N. Brothers
Adverse drug reactions (ADRs) have an impact on patient morbidity and mortality. Palliative care patients constitute a vulnerable population due to the complexity of their care and treatments. This study sought to identify ADRs in palliative care, assess their severity and preventability, and identify specific medications most commonly involved. This retrospective cohort study included patients who received a consult by the hospital’s palliative care service over a 1-year period. Records were reviewed to identify ADR occurrences, causative and resulting events, and variables used to determine preventability and severity. Of the 430 patients who met inclusion criteria, 247 patients experienced an ADR (57.4%). In total, 440 ADRs were documented, with 45.7% of patients experiencing more than one. Patients with repeated hospitalizations, increased medication usage, documented drug allergies, and cancer diagnoses were more likely to experience an ADR. No associations were found between occurrences of ADR with gender or Charlson comorbidity scores. The majority of ADRs were of moderate severity (64.6%) and considered potentially preventable (81.5%). Organ systems most commonly affected by ADRs were gastrointestinal (32.7%) and neurological (15.9%). Antimicrobials, opioids, and anticoagulants were the most common causative agents. ADRs are commonly experienced in palliative care patients and are often preventable. Identification of risk factors for ADRs may prevent occurrences in the complex palliative care patient.

17 October 2024 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
MHMennatullah Hasan
Mennatullah Hasan
KMKimford J. Meador
Kimford J. Meador
TBTodd N. Brothers
Todd N. Brothers
SWShuang Wang
Shuang Wang
ALAdam K. Lewkowitz
Adam K. Lewkowitz
XWXuerong Wen
Xuerong Wen